An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who was taking Wegovy (a prescription weight-loss drug) shared a personal story: they used it from July 2025 to March 2026, got up to the 1 mg dose, lost about 33 pounds, then stopped because they became very sick (they think it might have been the medication). After stopping, they kept exercising and eating fewer calories, lost another 12 pounds on their own, and stayed around 220 pounds for months without feeling hungrier — until recently, when something changed (the snippet cuts off before they finished the story). Wegovy is the brand name for semaglutide when it’s prescribed for weight loss. Semaglutide is a man-made version of a natural hormone that your gut releases after eating. That hormone talks to your brain and helps you feel full, and it also slows how quickly your stomach empties. In people taking Wegovy, those effects tend to reduce appetite and help lower how much they eat, which can lead to steady weight loss over time. What this personal report shows is one person’s experience, not a scientific study. They had a clear weight-loss response while on the drug (about 33 pounds), then kept losing another 12 pounds after stopping by maintaining exercise and calorie control. That suggests two things: the medicine helped produce significant initial weight loss, and behavioral habits afterward helped them continue losing and keep the weight off for a while. But this is an anecdote — one person’s timeline — so it can’t tell us how typical this pattern is, how often people get sick enough to stop, or what will happen long-term. Why it matters: many people are curious about whether drugs like Wegovy spark short-term losses that you can preserve by changing habits, or whether stopping will cause hunger and swift regain. This story shows that continuing exercise and keeping calories in check can maintain or even extend weight loss after stopping the drug, at least for some people. It’s relevant to anyone thinking about starting, stopping, or pausing semaglutide-type treatments and wondering what role behavior plays alongside medication. Important caveats and risks: this person stopped because they got “really sick,” which they think was possibly from the drug — that highlights that side effects can be serious enough to halt treatment. Common side effects of semaglutide include nausea, vomiting, diarrhea, and stomach pain; less commonly, there can be more severe reactions. Also, individual responses vary a lot: some people regain weight quickly after stopping, others don’t. Semaglutide is a prescription medication and should be used under medical supervision; don’t assume the same outcome without talking to a clinician. Regulatory guidance and long-term safety data continue to evolve. Bottom line: This is one person’s mixed experience with Wegovy — big initial loss, continued progress after stopping due to sustained habits, but also a concerning illness that ended treatment — useful as a single story, not proof of what will happen for everyone.
Source: r/Semaglutide